Trends in usage of erythropoietin-stimulating agents and blood transfusions for cancer-related anemia since implementation of the ESA APPRISE program
2015
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI